Concepedia

Daniel Kalinovsky

DK

Statistics

Publications

4

Citations

131

H-Index

4

Active since

2019

Affiliations

Sechenov University(Current)

Institute of Bioorganic Chemistry

Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology

Lomonosov Moscow State University

Daniel Kalinovsky is an author at Sechenov University specializing in medicine, tumor microenvironment, and immunology.

ORCID

Top concepts

Publications per year

2019–2023

4

Publications

4

RNA Sequencing-Based Identification of Ganglioside GD2-Positive Cancer Phenotype

Maxim Sorokin, Daniel Kalinovsky, Igor I. Doronin et al. · Biomedicines · 2020 · 46 citations · Full text

Therapeutic efficacy of antibody-drug conjugates targeting GD2-positive tumors

Daniel Kalinovsky, E. V. Svirshchevskaya, Igor I. Doronin et al. · Journal for ImmunoTherapy of Cancer · 2022 · 31 citations · Full text

Multimerization through Pegylation Improves Pharmacokinetic Properties of scFv Fragments of GD2-Specific Antibodies

Daniel Kalinovsky, E. V. Svirshchevskaya, Igor I. Doronin et al. · Molecules · 2019 · 29 citations · Full text

, , +19

Minibody-Based and scFv-Based Antibody Fragment-Drug Conjugates Selectively Eliminate GD2-Positive Tumor Cells

Daniel Kalinovsky, Igor I. Doronin, E. V. Svirshchevskaya et al. · International Journal of Molecular Sciences · 2023 · 25 citations · Full text

, , +15

1–4 of 4